TransCure Biosciences (TCB) is providing humanized immune system (HIS) mice for pharmaceutical companies and the scientific community as models for immune diseases (e.g. HIV/AIDS, cancer, oter infectious diseases and antibody testing.
26.04.2024
Three Geneva Tech Projects awarded FIF Funding (startupticker.ch)
19.12.2023
Aiming for faster growth with new Board members (startupticker.ch)
15.08.2014
TransCure bioServices raises € 0.7 million (startupticker.ch)
16.05.2013
Transcure Biosciences wins venture kick award of CHF130‘000 (startupticker.ch)
02.04.2013
Swiss Start-ups that master the art of selling (startupticker.ch)
No milestones
No Jobs
TransCure @ Global Pitchfest in Boston
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
The Venture Leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Website:
www.transcurebioservices.com/
Headquarter:
Genève
Foundation Date:
December 2011
Technology:
Sectors: